LIPIODOL

This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, France, Hong Kong, Ireland, Israel, Japan, Malta, New Zealand, Romania, Singapore, Tunisia, United States

Active ingredients

The drug LIPIODOL contains one active pharmaceutical ingredient (API):

1 Ethyl esters of iodised fatty acids of oleum papaveris UNII KZW0R0686Q - ETHIODIZED OIL

Read about Ethiodized oil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V08AD01	Ethyl esters of iodised fatty acids	V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AD Non-watersoluble X-ray contrast media
Discover more medicines within V08AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 511000501155412
Country: CA	Health Products and Food Branch	Identifier(s): 00386685
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5798-MEE-1220
Country: EE	Ravimiamet	Identifier(s): 1125100
Country: FR	Base de données publique des médicaments	Identifier(s): 65000980
Country: HK	Department of Health Drug Office	Identifier(s): 33227
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8917
Country: JP	医薬品医療機器総合機構	Identifier(s): 7211404X1037
Country: MT	Medicines Authority	Identifier(s): AA565/72301, AA565/72302
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 595
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65424001
Country: SG	Health Sciences Authority	Identifier(s): 06035P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5640051
Country: US	FDA, National Drug Code	Identifier(s): 67684-1901